Recombinant human nerve growth factor injection approved for clinical trial
On November 28, 2018, the class 1 new biological drug "recombinant human nerve growth factor injection" developed by our company obtained the clinical trial approval document issued by the State Drug Administration.
View details
The drug sensitivity test kit for gram negative bacteria (concentration gradient agar strip method) obtained the product registration certificate
On December 25, 2018, our innovative product "drug sensitivity test kit for gram negative bacteria (concentration gradient agar strip method)" obtained the medical device registration certificate (in vitro diagnostic reagent) issued by Jiangsu provincial drug administration.
View details
Fungal susceptibility test kit (concentration gradient agar strip method) successfully launched
On July 10, 2018, the innovative product "fungal susceptibility test kit (concentration gradient agar strip method)" developed by our company obtained the medical device registration certificate (in vitro diagnostic reagent) and production license issued by Jiangsu Provincial Drug Administration, and was successfully listed on the market.
View details
Who calls for attention to antibiotic resistance
Who calls for attention to antibiotic resistance
View details
Antibiotic infusion banned! Involving 460 large hospitals (with a list of 53 diseases without transfusion)
Antibiotic infusion banned! Involving 460 large hospitals (with a list of 53 diseases without transfusion)
View details
Prenatal screening is angry—— Do you know, do you know
Prenatal screening is angry—— Do you know, do you know
View details
Quick navigation
Home 丨 About us 丨 R & D platform 丨 Product 丨 Contact us
Contact us
Address: Building 7, Kangyuan medical science and Technology Park, 578 longmian Avenue, Jiangning District, Nanjing City, Jiangsu Province
Postal Code: 211100
Contact information: 025-58310595 (switchboard)
Fax: 025-58310595-108
Scan
Copyright © 2021 Jiangsu Zhongxin Pharmaceutical Co., Ltd 苏ICP备11074983号-1 Powered by：www.300.cn
